Extraction of Designer Stimulants from Urine Using ISOLUTE® SLE+ prior to GC/MS Analysis

Significance of the Topic

The reliable extraction and analysis of designer stimulants and related psychoactive compounds from biological fluids is crucial for forensic, clinical and anti-doping laboratories. Streamlined sample preparation methods that deliver high recoveries, low variability and compatibility with GC/MS workflows enhance throughput and data quality while reducing solvent usage and operator time.

Objectives and Overview

This study demonstrates an optimized protocol for isolating a broad panel of recreational stimulants (including 5-APB, 6-APB, pMMA, BZP, TFMPP, 2C-B, mCPP) from 1 mL urine samples using ISOLUTE® SLE+ supported liquid extraction prior to GC/MS analysis. The method aims to achieve quantitative recoveries, low limits of quantitation and robust calibration performance.

Methodology and Instrumentation

The workflow comprises:

• Sample pre-treatment: Spike 1 mL urine with amphetamine-d5 internal standard, dilute 1:1 with 1% ammonium hydroxide.
• SLE extraction: Load onto 1 mL ISOLUTE SLE+ columns (Part 820-0140-C), adsorb 5 min, elute twice with 2 mL MTBE under gravity, followed by a brief vacuum assist.
• Evaporation and derivatization: Dry extract under air or nitrogen, reconstitute in ethyl acetate/0.2 M HCl, dry and derivatize with pentafluoropropionic anhydride at 70 °C for 30 min, then reconstitute in ethyl acetate.

Applied Instrumentation

• ISOLUTE SLE+ 1 mL Supported Liquid Extraction columns
• Agilent 7890A GC with QuickSwap inlet, Zebron ZB-Semivolatiles column (30 m × 0.25 mm × 0.25 µm)
• Agilent 5975C MSD in SIM mode (helium carrier, temperature program from 55 to 330 °C)
• SPE Dry or TurboVap concentrators for solvent evaporation

Main Results and Discussion

The protocol delivered:

• Analyte recoveries of 105–109% (n=7), RSD <10% across multiple donors.
• Linear calibration (10–500 ng/mL) with r2 values of 0.992–0.996.
• Lower limits of quantitation: 10 ng/mL for most analytes; 20 ng/mL for 2C-B.

The clean extracts and consistent SIM responses support reliable quantitation of trace-level stimulants in urine.

Benefits and Practical Applications

• High throughput: minimal sample handling, no emulsions.
• Versatility: applicable to a range of designer stimulants and potential cathinone analogs.
• Scalability: compatible with automated positive-pressure manifolds and multi-sample concentrators.

Future Trends and Possibilities

Further enhancements may include exploration of alternative elution solvents (e.g., DCM), automated on-line SLE solutions, and extension to novel psychoactive substances. Advances in derivatization reagents and tandem MS detection will expand compound coverage and lower quantitation limits.

Conclusion

The presented ISOLUTE SLE+ protocol offers an efficient, reproducible and sensitive approach for extracting designer stimulants from urine. With excellent recoveries, low variability and straightforward sample preparation, the method is well-suited for forensic and clinical screening laboratories.

Reference

• Biotage Application Note AN776: Extraction of Bathsalts (Substituted Cathinones) from Human Urine using ISOLUTE SLE+ prior to GC/MS Analysis.
• ISOLUTE SLE+ User Guide, Biotage.